Who is sponsoring NCT05978882?

NCT05978882 is sponsored by National Cancer Center, Korea.

What drugs are being tested in NCT05978882?

Interventions in NCT05978882: Laparoscopic sentinel navigation surgery using fluorescence.

What condition does NCT05978882 study?

NCT05978882 studies Early Gastric Cancer.

Is NCT05978882 still recruiting?

NCT05978882 is currently not yet recruiting. Last updated 7 August 2023.

Last reviewed 2023-08-07 · How we verify

NCT05978882

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Feasibility Study of Sentinel Navigation Surgery in Early Gastric Cancer Using Fluorescence (SENORITA4)

Not yet recruiting NA Last updated 7 August 2023

What this trial tests

NA trial testing Laparoscopic sentinel navigation surgery using fluorescence in Early Gastric Cancer in 203 participants. Not yet recruiting.

Timeline

17 August 2023

Primary endpoint
31 December 2025

31 December 2030

Quick facts

Lead sponsor	National Cancer Center, Korea
Phase	NA
Status	Not yet recruiting
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	203
Start date	17 August 2023
Primary completion	31 December 2025
Estimated completion	31 December 2030
Sites	7 locations across South Korea

Drugs / interventions tested

Laparoscopic sentinel navigation surgery using fluorescence

Conditions studied

Early Gastric Cancer — all drugs for Early Gastric Cancer →

Sponsor

National Cancer Center, Korea

Who can join

Adults 20 to 80, any sex, with Early Gastric Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

SENORITA 1 trial showed laparoscopic sentinel lymph node biopsy and stomach preserving surgery in early gastric cancer can increase the quality of life. (Ryu KW et al. JCO 2022) The radioactive isotope is difficult to use because of the hazard of radiation and shortage of materials. The aim of this study is to investigate whether laparoscopic sentinel lymph node biopsy and stomach-preserving surgery using only fluorescence is feasible.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Feasibility of Regional Lymphadenectomy for Stomach-Preserving Surgery in Early Gastric Cancer Omitting Sentinel Node Navigation: A Post Hoc Analysis of the SENORITA Trial.
Park SH, Kim YW, Min JS, Yoon HM, et al · · 2024 · PMID 39085549 · DOI 10.1245/s10434-024-15950-1

Verify or expand the search:

Other recruiting trials for Early Gastric Cancer

Currently open trials in the same condition.

NCT07253948 — Distribution Characteristics of Helicobacter Pylori · recruiting
NCT06962293 — Magnetic Guided Counetrtraction During Endoscopic Submucosal Dissection · NA · recruiting
NCT06748352 — Safety and Efficacy of Traction Robot-assisted Endoscopic Submucosal Dissection for Early Gastric Cancer · NA · recruiting
NCT06788548 — Fluorescence Guided Laparoscopic-Endoscopic Cooperative Sentinel Lymph Node Navigation Surgery Strategy for Early Gastri · NA · recruiting
NCT05323929 — The Relationship Between Scar Formation and ESD Depth in Therapy for Gastric Carcinoma · NA · recruiting

Other National Cancer Center, Korea trials

Trials by the same sponsor.

NCT07399561 — Effect of Exercise on Chemotherapy-Induced Peripheral Neuropathy · NA · not yet recruiting
NCT07121478 — Patients With High-grade Pancreatic Neuroendocrine Tumors · Phase 2 · enrolling by invitation
NCT07171528 — Secondary Cytoreductive Surgery After Chemotherapy for Recurrent Epithelial Ovarian Cancer · Phase 2 · recruiting
NCT07125924 — Intravesical Hyaluronic Acid (HA) for Preventing Radiation Cystitis on Bladder Cancer · NA · not yet recruiting
NCT07041515 — Knowledge-enhanced Digital Intervention to Prevent Low Anterior Resection Syndrome · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05978882 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by National Cancer Center, Korea
Last refreshed: 7 August 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05978882.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing